Tissue Regenix Group PLC
United KingdomFDA applicant, unverified
- Devices
- 1
What Tissue Regenix Group PLC makes
Tissue Regenix Group Plc makes the SurgiPure XD Reconstructive Tissue Matrix, a device used for tissue reconstruction.
The SurgiPure XD Reconstructive Tissue Matrix is a Class II medical device listed in the FDA 510(k) registry, and the company is based in the United States.
Catalogue
SurgiPure XD Reconstructive Tissue Matrix Ref K152206
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Tissue Regenix Group Plc have in the registry?
The registry currently lists 1 device for Tissue Regenix Group Plc. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tissue Regenix Group Plc's devices?
Among its 1 most recently registered device, Tissue Regenix Group Plc has devices listed in FDA 510(k) (1 device).
What risk classes do Tissue Regenix Group Plc's devices fall under?
Among its 1 most recently registered device, the classes recorded for Tissue Regenix Group Plc's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Tissue Regenix Group Plc in the registry?
The most recently registered devices listed for Tissue Regenix Group Plc include SurgiPure XD Reconstructive Tissue Matrix.